Thymic development of committed pro-T-cells from multipotent hematopoietic precursors offers a unique opportunity to dissect the molecular circuitry establishing cell identity in response to environmental signals. This transition encompasses programmed shutoff of stem/progenitor genes, upregulation of T-cell specification genes, extensive proliferation, and commitment after a delay. We have incorporated these factors, as well as new single cell gene expression and developmental kinetics data, into a three-level dynamic model of commitment based upon regulation of the commitment gene Bcl11b. The first level is a core gene regulatory network architecture determined by transcription factor perturbation data, the second a stochastically controlled epigenetic gate, and the third a proliferation model validated by growth and commitment kinetics measured at single-cell levels. Using expression values consistent with single molecule RNA-FISH measurements of key transcription factors, this single-cell model exhibits state switching consistent with measured population and clonal proliferation and commitment times. The resulting multi-scale model provides a powerful mechanistic framework for dissecting commitment dynamics.
INTRODUCTION
Hematopoietic progenitors continually replenish the body's supply of blood cells including T lymphocytes. Many of the important regulatory factors controlling Tlineage commitment are known (reviewed in 1, 2 ) , as well as their patterns of expression [3] [4] [5] . Specific targets of several of these factors have been defined by perturbation studies, providing a strong basis for understanding the dynamic operation of an intrinsic gene regulatory network (GRN) . However, the timing of observed transitions and evidence for a rate-limiting role of epigenetic constraints prevent modeling of the commitment process through a simple factor-target interaction approach. This paper presents a three-level model that integrates current understanding of this intrinsic GRN with insights into epigenetic control points and population dynamics characterizing T-cell commitment.
Small numbers of multipotent hematopoietic precursors migrate continuously from bone marrow into the thymus 27, 28 where they enter the T-cell developmental pathway, driven by Notch signalling and cytokines in the thymic microenvironment. These early progenitor cells are CD4 and CD8 double negative (DN), as well T-cell receptor negative. The Kit high early thymic progenitors (ETP or DN1) proliferate before transitioning to DN2, a step marked by CD25 surface expression, then upregulate Bcl11b and undergo Bcl11b-dependent T-lineage commitment (Fig. 1A) 13, 14, 24, 29, 30 .
Expression of the zinc finger transcription factor Bcl11b not only alters many aspects of genomic activity and cell function 24, 31, 32 , but also correlates with the functional committed state of single DN2 cells 24 and can thus serve as a proxy for commitment.
After Bcl11b activation Kit high DN2a cells move through DN2b into the Kit low DN3 stage, after which they can continue differentiation after rearranging a signalling competent T-cell receptor (Fig. 1A) . A broad shift in expression of multiple regulatory genes occurs during commitment, and the stem/progenitor transcription factors expressed in DN1 and DN2 stages are generally extinguished (reviewed in 1, 33 ). 3 An important question is how the T-cell commitment decision is controlled.
Computational modelling of GRNs represents an important approach for studying mechanisms controlling cell-fate decisions 34 Earlier dynamical models dealt with the flux of T-cell progenitor populations through the DN1 to DN4 stages 35 and the transcriptional network for Bcl11b activation assuming deterministic, direct transcriptional regulation by positive regulators Notch, GATA3, and TCF-1 36 . Both models incorporated experimental evidence, but when juxtaposed, a contradiction emerged. The population model 35 showed that primitive T-cell precursors transit from DN1 to DN2 after 7-10 cell divisions in vivo. Activation of Bcl11b takes place even later, 2-4 days after the cells become CD25 + DN2s in vitro 24 . However, all components of the transcriptional GRN model 36 are expressed in the DN1 stage. A simple combination of previous models would predict Bcl11b to be turned on multiple cell cycles earlier than it is, well beyond the range of measurement error, suggesting that the deterministic assumption about Bcl11b control itself was incorrect or incomplete.
Incorporating a separate, stochastic timing step downstream of a deterministic network could reconcile these features. In fact, recent evidence implies that the timing discrepancy reflects an intervening epigenetic event. Extensive repression marks and methylation are removed from the Bcl11b locus during its activation 37, 38 , and the two alleles of Bcl11b within the same DN2 cell nucleus can become activated at different times, with discordances of up to 2+ days (and several cell cycles) despite exposure to the same transcription factors 39 . Consequently, in the model proposed here, an additional stochastic timing event for epigenetic activation has been interposed downstream of the action of the initial trans-acting regulators. This additional stochastic step, governed by a new composite parameter, X, and opposed by positive inputs Runx1 and Notch, permits the model to mimic the observed biological time course while using realistic rate constants and parameter values for the regulatory factors that agree with measured values in single cells.
Using these published data and our new experimental results, we propose a threestage dynamic model of early T-cell commitment. The gene network aspects of the model take into account the unique linkage of commitment to Bcl11b activation, and encompasses transcription and epigenetic levels of Bcl11b regulation to account for its proximal activation kinetics ( Fig. 1) . Step 
RESULTS

Experimental Results
Proliferation and Development from DN1 (ETP) to Commitment
Cells already within the DN2 stage, but still Bcl11b-nonexpressing, require ~2 days on average for Bcl11b activation 24 . However, to relate the output of committed cells to events potentially occurring days earlier, we required new benchmark measurements of proliferation and development kinetics from DN1 to T-lineage commitment, and in particular the intervals between the DN1-DN2 transition and Bcl11b activation in individual clonal lineages. Bulk and clonal cultures were therefore analysed, starting with DN1 cells purified from thymi of Bcl11b-YFP reporter mice 24 ( Fig. 2A ). Sorted DN1s were stained with Cell Trace Violet (CTV) dye that tracks each 5 cell's proliferation history through dilution, and then co-cultured with Notch-ligandexpressing OP9-DL1 stromal cells and growth-supporting cytokines, IL-7 and Flt3L, to promote T-lineage development. Parallel DN1 cultures were harvested after 2-5 days and assessed by flow cytometry for total cell numbers, CTV-fluorescence intensity, the developmentally-regulated surface marker, CD25 (marking transition to DN2), and Bcl11b-YFP (Fig. 2B ). The number of divisions each cell had experienced was determined by flow cytometric measurement of residual CTV staining as Approximately 50% of DN1 cells turned on CD25 by day 2 of culture, with increasing percentages over time ( Fig. 2B,D) . However, few Bcl11b-YFP + cells appeared among the CD25 + cells until day 3, with percentages of YFP + CD25 + cells then increasing over time ( Fig. 2B,D) . CTV analysis at day 2 showed that cell division was not required for CD25 expression (red dots=cells with 0 divisions), and that the most rapidly dividing cells were neither most or least likely to turn on CD25. By days 4-5, CD25 + cells had divided more rapidly than cells remaining CD25 -, as seen by the shift towards a larger population with the lowest CTV levels (turquoise or lilac) ( Fig. 2B ). Bcl11b-YFP was not expressed in non-proliferating cells, and Bcl11b-YFP + cells appeared to have proliferated more rapidly than cells remaining Bcl11b-YFPby days 4 and 5, since YFP + cells generally retained lower CTV levels ( Fig. 2B ). Overall, these results confirm that CD25 is expressed before Bcl11b-YFP ( Fig. 2B ,D) and that CD25 can be turned on without cell division, while Bcl11b-YFP cannot. Furthermore, more developmentally advanced cells in these cultures proliferated somewhat faster than those that were delayed.
Clonal Kinetic Analysis of Differentiation from DN1
Because DN1s divide at different rates, the output populations become dominated over time by progeny of the most rapidly proliferating input cells. To resolve at a clonal level whether Bcl11b expression depends on time or cell cycles, individual thymic DN1 cells were co-cultured with OP9-DL1 stroma in microwells and microscopically imaged over time 24 (Fig. 3A ). DN1s were purified from thymi of mice with a 6 constitutively-expressed membrane-(m)Tomato transgene, for cell segmentation and counts, as well as the nuclear Bcl11b-YFP reporter, and plated into microwells preseeded with OP9-DL1 cells. Microwells verified to start with single live DN1 cells were imaged daily for 6-7 days to determine clonal expansion and onsets of surface CD25 S4 ), in agreement with CTV data. There was wide variability in the timing of CD25 and Bcl11b-YFP expression between clones (Figs. 3F, S2). CD25 came on most frequently on days 1-2 (76%) although 16% of clones did not turn on CD25 until >4-5 days of culture, while times to the onset of Bcl11b-YFP expression ranged from 3-7 days. CD25 up-regulation was not synchronous within some clones, hinting at a stochastic element even in the transition to DN2.
To test the determinism of commitment programming, we asked whether cells are programmed to turn on Bcl11b after a fixed period of time or fixed number of cell cycles after making the DN1-DN2 transition. Fig. 3F shows the differences for each clone between the times when >50% of cells were scored as CD25 + and as Bcl11b-YFP + , in elapsed time and in cell cycles (Fig. 3F ). In fact, the intervals between entering the DN2 state (CD25 + ) and commitment (Bcl11b-YFP + ) were highly variable both in 7 absolute times and in cell cycles, taking from <1 to >5 days and from 1 to 7 cell divisions. Furthermore, Bcl11b-YFP was not turned on synchronously within a clone, generally requiring 2-3 days from expression in the first cells to expression in 100% of the cells (Figs. 3C (well 23, day 4), S2). Thus, daughter cells from individual DN1 cells are not only heterogeneous in their clonal founders' differentiation states, but also show a large stochastic element in timing of Bcl11b up-regulation after entering the DN2 state 39 .
Single Cell RNA-FISH Measurement of Key Transcription Factors
Potential drivers of commitment include TCF1 (Tcf7), Gata3, and Runx1, which are necessary positive inputs for Bcl11b expression 24 , while PU.1 (Spi1) antagonizes developmental progression through commitment 23, 40 . To determine the normal ranges of expression of Spi1, Tcf7, Runx1 and Gata3 in individual T-cell precursors in developmental stages leading up to Bcl11b activation for the model, DN thymocytes were purified from 5-week-old mice and analysed by multiplex single molecule RNA-FISH (smFISH) ( Fig. 4A,B ). Developmental stages of individual cells were scored based on measured Kit, CD25 protein and mRNA levels. Absolute transcript counts showed that Runx1, Gata3, and Tcf7 expression was variable in DN1s, increasing up to 2x in DN2s (DN2 median transcript levels/cell: Tcf7»40; Runx1»12; Gata3»8) ( Fig.   4C ). In contrast, Spi1 was highest in DN1 and DN2, and declined with further development, in accord with previous bulk population measurements. Bcl11b was not expressed in DN1s but turned on in CD25 + DN2s (median transcripts/cell»15), remaining high into DN3 ( Fig. 4C ).
These gene expression changes from DN1 to DN2 were used as input to the GRN model as an approximation for developmental changes in transcription factor protein.
The half-lives of these proteins can differ substantially; for example, PU.1 has a halflife at least 10x that of TCF1, Runx1, and Gata3 36, 41 , and so we used their relative expression patterns, rather than absolute protein levels.
Modelling Results
As described earlier, a GRN model for Bcl11b activation during commitment should incorporate three separate aspects of control. First, four positive regulatory inputs, 8 Notch signaling, TCF1, Gata3, and Runx1, are needed in the DN1-DN2a stages to make Bcl11b eligible for activation. Second, TCF1 and GATA3 work in a hit-and-run way and are dispensable for the final steps of Bcl11b induction, but Runx1 and Notch act through DN2a stage 24 . Third, activation of each Bcl11b allele, in a cell that has already fulfilled eligibility requirements, still requires a slow stochastic epigenetic remodelling process 39 . To accommodate these requirements, we separated an initial, deterministic process from a subsequent, stochastic process ( Fig. 1B) .
Thus, we developed a three-level dynamic model. 
The Gene Regulatory Network Architecture
For the first level of the single cell model we proposed a GRN architecture based upon gene expression, perturbation experiments and literature (Table 1) , describing the interplay between the T-cell commitment genes Tcf7, Gata3, Runx1 and the opposing gene Spi1 (Fig. 6A ). Rather than having these regulators controlling Bcl11b transcription directly, we proposed that their inputs collectively removed the obstruction from an antagonist of Bcl11b opening, X, representing a composite of the slow chromatin opening mechanism and the actions of any additional DN1-specific antagonists of Bcl11b expression, still to be defined. Only X, Notch signalling, and Runx1 then propagate to the next, stochastic level.
Parameter Setting Based on Pseudo-Time-Series
From the single cell FISH data ( Fig. 4 ), we created pseudo-time-series from DN1 through DN2, which show that in early DN1 expression of Tcf7 increases substantially and becomes predominant ( Fig. 6B ). After a delay (200 arbitrary time units), Bcl11b transcription begins. Furthermore, Gata3 expression slightly rises with increasing Tcf7 expression, along with Runx1. Expression of the opposing gene PU.1 is fairly constant at a low level through these stages, turning off later. The GRN model parameters (Table S1 ) were optimised from these pseudo-time-series ( Fig. S5 ).
Transcriptional Level -Deterministic Simulations
We developed the computational model for the step 1 GRN ( Fig. 6A ) with Shea-Ackers deterministic rate equations 42 (Methods). Deterministic simulation results from the model (with initial conditions for Tcf7, Gata3, PU.1 and Runx1 equal to the first pseudo-time-series expression values and the X function initially highly active) show that the system, when exposed to external Notch signalling, moves towards a steady state where the T-cell factors are highly expressed, with a pronounced increase in Tcf7, while PU.1 and X activity levels descend towards low values.
Transcriptional Level -Stochastic Simulations
Stochastic simulations 43 of the GRN model ( Fig. 7A ) in individual cells with the same parameters (Table S1) show that noise could be a source of heterogeneity in DN1 cells, as not all simulations exhibited dynamic switching towards a steady state with high T-cell factors (Fig. 7C ). Moreover, the stochastic simulations showed that GRN intrinsic noise sometimes leads to delays of the switch towards T-cell commitment.
Epigenetic Level
The second level of modelling consists of a simplified epigenetic model for the Notch signalling augments the likelihood of activation per unit time 24 , while Runx1 positively modulates expression levels 24, 39 . Therefore, our model places these regulators in opposition to function X (Fig. 8A,B ).
To account for the slow and potentially processive nature of this epigenetic transition, 
Merging Transcriptional with Epigenetic Levels
We next conducted stochastic simulations of the single cell multi-level model incorporating Bcl11b regulatory region state dynamics predicting that early T-cell progenitor cells are heterogeneous in their CpG methylation states 37 or equivalent open/closed chromatin states in the Bcl11b regulatory regions. The simulations showed that the Bcl11b locus can remain closed or become opened depending on the status of these CpG (or equivalent) sites, as dictated by Notch signalling, Runx1 expression, and opposing X activity (Fig. 7D ). The stochastic treatment of the epigenetic level predicits further delays in T-cell commitment. In an example when the switch is thrown by day 3 (i.e., Tcf7 and Gata3 becoming highly expressed while X activity drops), the corresponding stochastic simulation of Bcl11b status showed that the regulatory system only opens after day 4 ( Fig. 7C , lower panels).
Based on three sets of 100 stochastic simulations of this multi-level model, the model predicted that on days 2 and 3 <20% of cells would express Bcl11b, ~40% on day 4, and ~50% on day 5. These predictions agree well with direct monitoring of Bcl11b-YFP during 5 days in DN1-derived populations going through commitment ( Fig. 2D,   3D ). The distributions of cell percentages with low X-levels ( Fig. 7F ) are very similar to the distributions of CD25-positive cells (Fig. 2D, 3D ), suggesting that loss of X activity might be correlated to CD25 expression, consistent with the observation that 
Population Model
To capture population dynamics, we developed population models based upon CTV data. We first tested the hypothesis that cell cycle length is independent of generation, which was clearly incorrect (Supplementary Material). We then relaxed this assumption, with each cell having its division time stochastically determined from a normal distribution with mean and variance depending upon cell generation ( Fig. 8A ).
Normalised cell number distributions among different generations within simulated
cell cultures up to day 5 were compared to the CTV data ( Fig. 3C ), allowing us to determine the cell cycle distribution parameters (Table S3 ). We monitored each cell generation, and calculated the proportion of cells in each generation at each day from 172 simulations ( Fig. 8B) with resulting distributions very similar to experimental data ( Fig. 3C ).
Full Multi-scale Model
We next implemented the single-cell GRN model within the multi-cell simulation Notably, the optimal number of "CpG equivalent" units that needed to be derepressed was found to be 500, consistent with the very extended potential regulatory regions associated with the Bcl11b gene 32, 37 .
We computed the proportion of cells for which the Bcl11b regulatory region was in the open state in 172 simulations starting with one cell proliferating for five days. The model predicts that none of the cells have the Bcl11b regulatory region open at day 2, while at day 3 roughly 8% are open. The proportion then increases to 47% at day 4 and 60% at day 5 (Fig. 8C ). We also computed the percentage of cells that lose X activity at time points corresponding to each day ( Fig. 8C ). Our multi-scale model predicts that X activity is lost in ~50% of the cells by day 2, and the proportion lacking X gradually increases, reaching >70% by day 5. This proportion of cells predicted to have lost X activity ( Finally, the multi-scale model predictions were validated by imaging results from the 62 T-lineage DN1 clones ( Fig. 3) , corresponding to our model simulations starting with single clones and including cell divisions, GRN states and Bcl11b epigenetic dynamics. The single cell imaging experiments agree well with our model predictions that ~50% of the clones contained >50% CD25 + cells at day 2 while almost none of the cells were yet Bcl11b-YFP-positive ( Fig. 3D ). The proportions of clones with >50% CD25 + and >50% Bcl11b + cells then increased gradually, reaching more than 70% of clones by day 5 (Fig. 3D) .
The multi-scale model also predicted the variability in proliferation kinetics between simulated single cell clones (Fig. 8D ). The 'in silico' cell numbers were in good agreement with the observed ones ( Fig. 3E ). Furthermore, model predictions showed that the clones would not be fully synchronised, with 10/172 in silico "clones" producing 50% of Bcl11b + cells as early as day 3, with others waiting until day 4, 5 or even later (Fig. 8E ). Similar results are obtained from monitoring the proportion of clones reaching 50% of cells without X activity (i.e., 95 of the simulated clones lost X 13 activity at day 2 while 13 turned off X activity at day 5) ( Fig. 8F ). This agrees well with analysis for cultured and imaged DN1 clones, with variable timing for expression of both CD25 and Bcl11b (Fig. 3F) . Thus, the predicted DN1 clonal heterogeneity in differentiation was validated by experimental data. Whereas other hematopoietic stem cell commitment processes have been subject to mathematical model investigations 34 , few attempts have been made for early Tcells 36, 45 . Importantly, our model incorporates the complex molecular mechanisms shown recently to be involved in Bcl11b activation including the four known positive regulators contributing to the logic of Bcl11b activation, and the additional, slow epigenetic step that creates a stochastic delay in Bcl11b activation, long after the positive regulators are present. This level of control is probably not unique to Bcl11b regulation but has been demonstrated in particular depth for developmental activation of this gene 39 .
DISCUSSION
Computational models for epigenetics and GRNs were proposed in the context of pluripotency acquisition through cell reprogramming 44, 46 . Multi-scale modelling approaches, unifying observations from the intra-cellular to cell population scale, have also been used to model heterogeneity and function of mature peripheral T-cells, reviewed in 47 . This is, to our knowledge, the first time a computational model, which considers the epigenetic and genetic levels of regulation, is used to explain and predict dynamics of T-cell lineage commitment.
The choice to use continuous-valued rather than Boolean transcriptional models has the advantage of avoiding discretising the data in instances when experimental realvalued gene expression levels are relevant for the problem studied, as in this case.
On the other hand, with a Boolean approach one can probe larger networks than that modeled here. These issues have been briefly reviewed 34 Importantly, X is a composite function in this model, not a single undefined regulatory gene. As Bcl11b starts out in an epigenetically silent state inherited from hematopoietic stem cells, X measures the resistance to the opening of relevant cisregulatory elements at each allele of the locus. It is possible that some transcription factors inherited from stem/multipotent progenitors and still active in DN1 could sustain X, but this epigenetic constraint itself cannot be equated with a trans-acting repressor. Therefore, in the stochastic level of the model, we have taken the balance of Notch signals and Runx1 against decreasing X to drive a stepwise epigenetic opening process that we have modelled analogously to the removal of methylated CpGs. While demethylation may be part of this process, the use of this formalism is 15 more abstract here and indicates the stochastic but neighbour-biased and progressive nature that is shared by demethylation with other epigenetic opening processes.
Stochastic simulations of the GRN controlling the first steps in T-cell commitment show that the switch towards a state with low X-levels does not occur in a synchronised manner between model simulations with identical initial conditions. This suggests that GRN intrinsic noise could be a source of heterogeneity in the loss of X, which is one of the first steps in the T-cell commitment process and we speculate that it could be linked to the DN1 to DN2 transition marked by CD25 expression.
CD25 expression, the key marker of transition to DN2, was monitored in experiments but not included in the model. Nevertheless it provides several key insights into Bcl11b expression kinetics.
First, the timing of CD25 expression is quite heterogeneous in different DN1 clones, confirming DN1 cell heterogeneity 1, 35 .
Furthermore, the clonal analysis shows that CD25 + DN2 cells divide more quickly than CD25 -DN1s. One ramification of more rapid cell division is the dilution of proteins affecting the potential speed of epigenetic changes 48 . Finally, both CTV and clonal imaging confirm that Bcl11b is typically turned on days and many cell cycles after CD25, in every clone (Fig. 2,3 ). This is surprisingly comparable to the average and range of delays predicted between X function down-regulation and Bcl11b opening in the model, hinting at possible common regulatory elements yet to be determined.
In summary, this new model that integrates three distinct types of mechanistic control provides a quantitative understanding of commitment kinetics in early T cell precursors, and a valuable in silico tool to help discover new commitment regulators in this system.
METHODS
Mice
C57Bl/6, B6.Bcl11b yfp/yfp (Bcl11btm1.1Evr) reporter mice 24 cells were sorted as CD44high Kit high CD25-negative Bcl11b-YFP-negative cells. Note that for simplicity, throughout this paper, we use "DN1" to refer to the Kit high subset of CD44+ CD25-cells that contains the T-cell precursor function, also known as ETP.
Single Molecule Multiplex Fluorescent in situ Hybridization (sm-FISH)
Probe design and synthesis
The gene-specific primary probes for each gene tested were designed as previously described{Shah, 2016 #2362}, with some modifications: each probe comprised a mRNA-complementary 35-mer sequence plus a shorter "gene handle" sequence that was shared by all probes against the same gene. All probes were blasted against the mouse transcriptome and expected copy numbers of off-target probe hits were calculated using predicted RNA counts in the ENCODE database for murine thymocytes. BLAST hits on any sequences other than the target gene with a 15-nt match were considered off-target hits. Any probe that hit an expected total off-target copy number exceeding 500 in count table was dropped. Probes were sequentially dropped from genes until any off-target gene was hit by no more than 6 probes from the entire pool. At this stage, all of the viable candidate probes for each gene had been identified. For the final probe set, the best possible subset from the viable probes for each gene was selected such that none of the final probes used were within 2-nt bases of each other on the target mRNA sequence, with no-overlapping hybridization regions and GC-content close to 55%. Primary probes were synthesised and amplified from array-synthesised oligo-pool as previously described 49 The cells were segmented and categorised according to surface antibodies, and dots representing individual mRNA molecules were assigned to individual cells as shown in Fig. 4B .
Bulk cell cultures
For experiments on developmental kinetics DN1 cells were cultured on OP9-DL1 stromal cells as previously described 24, 29 in aMEM medium supplemented with Lglutamine, penicillin, streptomycin (OP9 culture medium) and IL-7 (5 ng/ml) and Flt3L (Fig. S1 ).
Clonal Image Analysis
To follow the kinetics of development and proliferation in individual DN1-derived clones by microscopic imaging, several technical problems had to be solved. First, to allow for accurate identification and segmentation of developing cells of varying shapes and sizes on a background layer of OP9-DL1 stroma, we needed to use cells purified from B6.R26m mTom/mTom Bcl11b yfp/yfp J mice expressing ubiquitous membrane Tomato (Jackson Laboratory). We then crossed and backcrossed this strain to our B6.Bcl11b yfp/yfp reporter mice 24 Developing T-cells are extremely active in motility, so individual DN1 cells had to be confined in wells for imaging. We used a protocol similar to our previous experiments with DN2 cells 24 , but we found that the background of the clear wells was too high in the fluorescence channels used in these experiments, so black microwells were substituted. Black 8mm circular poly (dimethyl siloxane) PDMS micromeshes with over 150 microwells punched/micromesh, each approximately 250 µM wide X 100 µM deep, were custom fabricated by Microsurfaces (Australia). One day before the start of co-culture and imaging these micro meshes were adhered to 2-4 (macro)wells of a 24-well glass-bottom plate (P24G-1.0-13-F) (MatTek, Ashland, CA), sterilized with ethanol, and washed in accordance with manufacturer's instructions, and then seeded with 5,000 OP9-DL1-delGFP stromal cells. Cultures were carried out in OP9 culture medium prepared as previously described except for the omission of pH indicator, phenol red, from the medium, which gives background fluorescence, and with the addition of 10mM Hepes buffer to stabilize the pH of the wells during imaging.
On the first day of culture the following were added to the medium: 10 ng/ml Flt3L, 5 ng/ml IL-7, and 0.05 µg/ml anti-CD25-AlexaFluor647 antibody (BioLegend) for detection of CD25 surface expression. DN cells were isolated from B6.ROSA26-mTom/Bcl11b-YFP mice and DN1 cells were FACS-purified as described above.
1,500 sorted DN1 cells were added to each well of the 24-well plate which had the microwells pre-seeded with OP9-DL1-delGFP. The cells were allowed to recover for at least one-hour at 37C, 7% CO2, before transfer to the Leica 6000 wide-field fluorescence microscope with Metamorph software and an incubation chamber preset to 37C, 7 % CO2. Each microwell was briefly checked using the 40X objective, which allowed imaging of one entire microwell, for mTomato-positive cells.
Microwells with 1 or 2 cells had their X-Y stage positions marked. All marked microwells were imaged daily using differential interference contrast (DIC) and three fluorescence channels: 504 excitation-542 filter for YFP, 560-607 for mTomato, and 650-684 for CD25-AlexaFluor647. Wells found to have one mTomato positive cell on either day 1 or 2 and cells present throughout the culture period were selected to further analysis. mTomato-positive cells were segmented and analysed using Fiji 
Pseudo time series
From the single cell FISH data, pseudo-time-series were created by clustering the data and ordering the clusters, assuming that the cells measured are in states distributed over the whole-time intervals of both stages DN1 and DN2. The data points were first classified into clusters with a Gaussian-Mixture algorithm 51 , assuming that they follow several Gaussian distributions with individual parameters. Moreover, the number of data points in each cluster should be similar in order to regard all data with the same significance. The mean expression and standard deviation of all data points in a cluster were then computed for each gene and used to arrange the clusters in time. The cluster order was set by the fact that both Tcf7 and Bcl11b expression levels are known to increase during cell commitment 52, 53 . We considered the relative values of gene expression levels with respect to the maximum level at each stage to prohibit Tcf7 from dictating the order of the clusters alone, since its absolute expression is higher than Bcl11b expression. For each cluster, expression values of Tcf7 and Bcl11b were added. Finally, the clusters were ordered such that this sum is increasing and placed equidistantly on an arbitrary time axis.
Single Cell Model -Transcription Level
For the circuit in Fig. 6A we obtained the following set of rate equations from a thermodynamic approach 42 . The equations describe the dynamics of T-cell specific or downregulation of any one of these regulators (see Table 1 for references). We modelled the Notch activity such that the N levels increase throughout the simulations, however, parameter p15 values were chosen to be very low to assure only (Table S1 ) were chosen such as the resulting expression levels dynamics for all the genes in the network are within the range levels of genes expression observed in the single cell FISH experiments (Fig. S6) . The model parameters were optimised (Supplementary Material) from the pseudo-time-series data using simulated annealing, genetic algorithms and a bound constrained optimisation algorithm (L-BFGS-B) 54 with the latter performing best.
Single Cell Model -Epigenetic Level
We implemented a simplified computational model for X activity is considered to help maintain a closed state of the Bcl11b regulatory system, dictating the probability of the regulatory region to be closed. We initially put forward a very simplified model in which we considered the size of the Bcl11b regulatory system to have a finite low number of CpG sites i.e. 20. This was chosen to make sure that the simulations were very fast, but that we considered enough CpG Table S2 .
The initial conditions for stochastic simulations of the epigenetic level model consider the Bcl11b regulatory system to be in closed state i.e. the number of closed CpG sites is greater than the number of sites considered to be open. In some simulations the 
Multi-scale model of proliferation and gene expression
To analyse the effects of cell proliferation on the population scale gene expression we the daughter cells inherit the mother cell content, but then evolve independently.
Since we assume that the presented network describes transition from DN1 to DN2a cell state in the multi-cell simulations we turn on the network in its initial state between day 1 and day 2 while the start of the simulation at day 0 corresponds to introduction of a single DN1 clone to the well.
We constructed a unified model of cell proliferation consistent with the data by assuming that the cell cycle length is a function of the cell generation. The parameters of the cell cycle length normal distributions were chosen independently for each cell based on its generation and fitted globally to the CTV data in Table S4 .
In order to take into account the effect of cell division on the amounts of epigenetic hemi-methylated states (Fig. S8 ). This type of collaborative model was proposed in 44, 48 and used here to simulate the opening and closing of the The collaborative model is described be the following set of equations:
The parameter values are shown in Table S5 . to demethylation of at least 500 CpG sites. Note that the real Bcl11b gene includes multiple methylated CpG islands in the gene body and also possesses extended enhancers spread over more than 850 million bp of DNA 32, 37 , so this constraint is quite likely to be biologically meaningful. 
